Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19.
Jiménez-Cortegana C, Sánchez-Jiménez F, Pérez-Pérez A, Álvarez N, Sousa A, Cantón-Bulnes L, Vilariño-García T, Fuentes S, Martín S, Jiménez M, León-Justel A, de la Cruz-Merino L, Garnacho-Montero J, Sánchez-Margalet V. Jiménez-Cortegana C, et al. Front Immunol. 2022 Jan 28;12:801410. doi: 10.3389/fimmu.2021.801410. eCollection 2021. Front Immunol. 2022. PMID: 35154077 Free PMC article.
Development and validation of a laboratory-based risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19.
Martin S, Fuentes S, Sanchez C, Jimenez M, Navarro C, Perez H, Salamanca E, Santotoribio JD, Bobillo J, Giron JA, Gonzalez J, Garrido JM, Liro J, Guerrero JM, Sanchez-Pozo MC, Sanchez-Margalet V, Leon-Justel A. Martin S, et al. Scand J Clin Lab Invest. 2021 Jul;81(4):282-289. doi: 10.1080/00365513.2020.1847313. Epub 2021 May 11. Scand J Clin Lab Invest. 2021. PMID: 33974458
Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization.
Jiménez-Cortegana C, Salamanca E, Palazón-Carrión N, Sánchez-Jiménez F, Pérez-Pérez A, Vilariño-García T, Fuentes S, Martín S, Jiménez M, Galván R, Rodríguez-Chacón C, Sánchez-Mora C, Moreno-Mellado E, Gutiérrez-Gutiérrez B, Álvarez N, Sosa A, Garnacho-Montero J, de la Cruz-Merino L, Rodríguez-Baño J, Sánchez-Margalet V. Jiménez-Cortegana C, et al. Front Immunol. 2023 Nov 14;14:1266659. doi: 10.3389/fimmu.2023.1266659. eCollection 2023. Front Immunol. 2023. PMID: 38035104 Free PMC article.
Serum protein electrophoresis in European mink (Mustela lutreola): reference intervals and comparison of agarose gel electrophoresis and capillary zone electrophoresis.
Villanueva-Saz S, Aranda MDC, Jiménez MLÁ, de Andrés PJ, Verde M, Climent M, Lebrero Berna ME, Marteles Aragüés D, Fernández A. Villanueva-Saz S, et al. Among authors: jimenez mla. Vet Q. 2024 Dec;44(1):1-11. doi: 10.1080/01652176.2024.2318195. Epub 2024 Feb 22. Vet Q. 2024. PMID: 38389258 Free PMC article.
Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the Omicron era: A prospective cohort study.
Calderón-Parra J, Gutiérrez-Villanueva A, Ronda-Roca G, Jimenez MLM, de la Torre H, Ródenas-Baquero M, Paniura-Pinedo M, Lozano-Llano C, Pintos-Pascual I, Fernández-Cruz A, Ramos-Martínez A, Muñez-Rubio E. Calderón-Parra J, et al. Among authors: jimenez mlm. Int J Antimicrob Agents. 2024 Mar;63(3):107095. doi: 10.1016/j.ijantimicag.2024.107095. Epub 2024 Jan 18. Int J Antimicrob Agents. 2024. PMID: 38244814 Free article.
Electro-optics of confined systems.
Cazorla A, Martín-Martín S, Delgado ÁV, Jiménez ML. Cazorla A, et al. Among authors: jimenez ml. J Colloid Interface Sci. 2024 Mar 15;658:52-60. doi: 10.1016/j.jcis.2023.11.180. Epub 2023 Dec 5. J Colloid Interface Sci. 2024. PMID: 38096679 Free article.
155 results